Craig Dais - Nov 10, 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Gioia Gentile for Craig Dais by power of attorney
Stock symbol
NAVB
Transactions as of
Nov 10, 2023
Transactions value $
$0
Form type
4
Date filed
11/14/2023, 04:38 PM
Previous filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +974K $0.00 974K Nov 10, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of stock vest in two tranches: 50% vest upon the date of the grant and the remaining 50% shall vest upon the one-year anniversary of the grant date, subject to Mr. Dais' continued employment with the Company.